Related references
Note: Only part of the references are listed.Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer
Edith A. Perez
BREAST CANCER RESEARCH AND TREATMENT (2009)
Guide to receptors and channels (GRAC), 3rd edition
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Forkhead box-O transcription factor: critical conductors of cancer's fate
Carl Weidinger et al.
ENDOCRINE-RELATED CANCER (2008)
Anthracycline cardiotoxicity: From bench to bedside
Luca Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Efficacy of selected natural products as therapeutic agents against cancer
Sanjeev Banerjee et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Cellular mechanisms of resistance to anthracyclines and taxanes in cancer: Intrinsic and acquired
A. Jo Chien et al.
SEMINARS IN ONCOLOGY (2008)
Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy
Frederique Wegran et al.
CLINICAL CANCER RESEARCH (2006)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
Promoting apoptosis as a strategy for cancer drug discovery
SW Fesik
NATURE REVIEWS CANCER (2005)
Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin
KF Hofland et al.
CLINICAL CANCER RESEARCH (2005)
Targeting apoptosis pathways in cancer therapy
IM Ghobrial et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line
S Lee et al.
GYNECOLOGIC ONCOLOGY (2005)
Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma
S Yamamoto et al.
CLINICAL CANCER RESEARCH (2004)
Cardiotoxicity of cytotoxic drugs
KJM Schimmel et al.
CANCER TREATMENT REVIEWS (2004)
FoxO3a transcriptional regulation of bim controls apoptosis in paclitaxel-treated breast cancer cell lines
A Sunters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Progress in the development and acquisition of anticancer agents from marine sources
ML Amador et al.
ANNALS OF ONCOLOGY (2003)
FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons
J Gilley et al.
JOURNAL OF CELL BIOLOGY (2003)
Marine-derived anticancer agents in clinical trials
G Schwartsmann et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2003)
Survival of patients with metastatic breast carcinoma - Importance of prognostic markers of the primary tumor
J Chang et al.
CANCER (2003)
Activation of the PI3K/Akt pathway and chemotherapeutic resistance
KA West et al.
DRUG RESISTANCE UPDATES (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Daunorubicin cardiotoxicity - Evidence for the importance of the quinone moiety in a free-radical-independent mechanism
SE Shadle et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Potent growth inhibition of leukemic cells by novel ribbon-type antisense oligonucleotides to c-myb1
IJ Moon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)